本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

15.10
-0.0700-0.46%
成交量:14.93萬
成交額:225.25萬
市值:13.16億
市盈率:-8.07
高:15.24
開:15.05
低:14.93
收:15.17
52周最高:36.26
52周最低:2.96
股本:8,715.70萬
流通股本:7,188.81萬
量比:0.67
換手率:0.21%
股息:- -
股息率:- -
每股收益(TTM):-1.8700
每股收益(LYR):-1.8700
淨資產收益率:-36.61%
總資產收益率:-21.42%
市淨率:2.75
市盈率(LYR):-8.07

資料載入中...

2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/22

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/16

重要事件披露

8-K - Current report
2022/11/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report